Bnc Wealth Management, LLC Abb Vie Inc. Transaction History

Bnc Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	BUY	$159.82 - $182.1 $179,957 - $205,044	1,126 New	1,126 $205,000
Q1 2023 Apr 21, 2023	BUY	$144.61 - $166.54 $723 - $832	5 Added 0.4%	1,261 $200,000
Q4 2022 Jan 23, 2023	BUY	$138.31 - $165.87 $173,717 - $208,332	1,256 New	1,256 $0
Q4 2020 Mar 05, 2021	SELL	$80.49 - $108.67 $66,243 - $89,435	-823 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$85.91 - $100.83 $70,703 - $82,983	823 New	823 $72,000

3,695

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Bnc Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bnc Wealth Management, LLC with notifications on news.